Although the exact roles of CCR4+/CD3+ cells and CD45RA−CD62L+/CD3+CD4+ cells are uncertain, the difference was significant between the GC and non-GC samples, whereas no significant difference was observed between the GC-peri-tumor and GC-body samples. The gene discussed is CCR4; the disease is gastric cancer.